Kalvista Pharmaceuticals Inc (KALV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 04/30
| 04-2020 | 04-2019 | 04-2018 | 04-2017 | 04-2016 | |
| Sales | 12,690 | 16,127 | 8,394 | 1,504 | 2,133 |
| Gross Profit | 12,690 | 16,127 | 8,394 | 1,504 | 2,133 |
| Operating Expenses | 53,223 | 45,947 | 27,099 | 23,843 | 17,314 |
| Operating Income | -40,533 | -29,820 | -18,705 | -22,339 | -15,181 |
| Other Income | 11,293 | 9,128 | 2,900 | 3,736 | 3,745 |
| Pre-tax Income | -29,240 | -20,692 | -15,805 | -18,603 | -11,436 |
| Income Tax | -124 | 124 | N/A | N/A | N/A |
| Net Income Continuous | -29,116 | -20,816 | -15,805 | -18,603 | -11,436 |
| Net Income | $-29,116 | $-20,816 | $-15,805 | $-18,603 | $-11,436 |
| EPS Basic Total Ops | -1.64 | -1.38 | -1.53 | -4.47 | -26.17 |
| EPS Basic Continuous Ops | -1.64 | -1.38 | -1.53 | -4.00 | -19.34 |
| EPS Diluted Total Ops | -1.64 | -1.38 | -1.53 | -4.47 | -26.17 |
| EPS Diluted Continuous Ops | -1.64 | -1.38 | -1.53 | -4.00 | -19.34 |
| EBITDA(a) | $-39,828 | $-29,442 | $-18,525 | $-22,299 | $-15,148 |